title: Insights into the pathogenesis of enteropathogenic E. coli using an improved intestinal enterocyte model.
abstract: Enteropathogenic E. coli (EPEC) is a human pathogen that targets the small intestine, causing severe and often fatal diarrhoea in infants. A defining feature of EPEC disease is the loss (effacement) of absorptive microvilli (MV) from the surface of small intestinal enterocytes. Much of our understanding of EPEC pathogenesis is derived from studies using cell lines such as Caco-2 - the most extensively used small intestinal model. However, previous work has revealed fundamental differences between Caco-2 cells and in vivo differentiated enterocytes in relation to MV effacement. This, and the high heterogeneity and low transfection efficiency of the Caco-2 cell line prompted the isolation of several sub-clones (NCL-1-12) to identify a more tractable and improved in vivo-like cell model. Along with established Caco-2 clones (TC-7, BBE1), sub-clones were assessed for growth rate, apical surface morphology, epithelial barrier function and transfection efficiency. TC-7 cells provided the best all-round clone and exhibited highest levels of ectopic gene expression following cell polarisation. Novel alterations in EGFP-labelled mitochondria, that were not previously documented in non-polarised cell types, highlighted the potential of the TC-7 model for defining dynamic enterocyte-specific changes during infection. Crucially, the TC-7 cell line also mimicked ex vivo derived enterocytes with regard to MV effacement, enabling a better dissection of the process. Effacement activity caused by the EPEC protein Map in the Caco-2 but not ex vivo model, was linked to a defect in suppressing its Cdc42-dependent functionality. MV effacement activity of the EPEC protein EspF in the TC-7 model was dependent on its N-WASP binding motif, which is also shown to play an essential role in epithelial barrier dysfunction. Together, this study highlights the many advantages of using TC-7 cells as a small intestinal model to study host-pathogen interactions.
authors: Institute of Cell and Molecular Biosciences, Medical School, University of Newcastle, Newcastle-Upon-Tyne, United Kingdom. p.dean@ncl.ac.uk
authors: Paul
authors: P
authors: Dean
authors: Lorna
authors: L
authors: Young
authors: Sabine
authors: S
authors: Quitard
authors: Brendan
authors: B
authors: Kenny
mesh_terms: D000704:Analysis of Variance; D018938:Caco-2 Cells; D017097:Electric Impedance; D020895:Enterocytes / Q000382:microbiology* / Q000473:pathology; D054308:Enteropathogenic Escherichia coli / Q000472:pathogenicity* / Q000648:ultrastructure; D054884:Host-Pathogen Interactions; D006801:Humans; D015151:Immunoblotting; D007421:Intestine, Small / Q000166:cytology*; D018613:Microscopy, Confocal; D008855:Microscopy, Electron, Scanning; D023421:Models, Animal
references: Cell Microbiol. 2010 Nov;12(11):1544-52
references: 20716205
references: Infect Immun. 1999 Oct;67(10):5538-40
references: 10496946
references: Biochem J. 1991 Dec 15;280 ( Pt 3):599-608
references: 1764023
references: J Cell Sci. 1994 Jan;107 ( Pt 1):213-25
references: 8175910
references: Mol Microbiol. 2004 Nov;54(3):665-75
references: 15491358
references: Cell Biol Toxicol. 2005 Jan;21(1):1-26
references: 15868485
references: Proc Natl Acad Sci U S A. 2006 Feb 7;103(6):1876-81
references: 16446436
references: Cell Microbiol. 2006 Jun;8(6):972-81
references: 16681838
references: Infect Immun. 2010 Nov;78(11):4445-53
references: 20679436
references: J Biol Chem. 2005 Jan 28;280(4):2998-3011
references: 15533930
references: Mol Cell Biol. 2002 Feb;22(4):1172-83
references: 11809808
references: Infect Immun. 2005 Feb;73(2):1243-51
references: 15664974
references: Cell Death Differ. 2011 Oct;18(10):1561-72
references: 21372848
references: PLoS Pathog. 2010 Jun 24;6(6):e1000961
references: 20585567
references: J Cell Biol. 2007 Sep 24;178(7):1265-78
references: 17893247
references: Cell. 1997 Nov 14;91(4):511-20
references: 9390560
references: J Pharm Sci. 2008 Feb;97(2):712-25
references: 17542022
references: Cell Microbiol. 2000 Dec;2(6):579-90
references: 11207610
references: Nature. 2008 Aug 21;454(7207):1009-13
references: 18650809
references: Cell. 2012 Feb 17;148(4):803-15
references: 22341450
references: Mol Microbiol. 2002 May;44(4):1095-1107
references: 12046591
references: J Cell Sci. 1992 Jul;102 ( Pt 3):581-600
references: 1506435
references: Mol Microbiol. 2011 Jun;80(6):1420-38
references: 21488979
references: Mol Microbiol. 2006 Apr;60(2):349-63
references: 16573685
references: Biotechnol Prog. 2006 Jan-Feb;22(1):186-98
references: 16454510
references: Mol Microbiol. 1996 Apr;20(2):313-23
references: 8733230
references: J Biol Chem. 2010 Apr 9;285(15):11740-52
references: 20164189
references: Microbiology (Reading). 2011 Jun;157(Pt 6):1761-1767
references: 21436219
references: Cell Microbiol. 2004 Nov;6(11):1097-111
references: 15469437
references: Expert Opin Drug Metab Toxicol. 2012 May;8(5):607-21
references: 22424145
references: Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):27-43
references: 11259831
references: Curr Opin Microbiol. 2009 Feb;12(1):101-9
references: 19144561
references: Nat Struct Mol Biol. 2009 Aug;16(8):853-60
references: 19620963
references: Cell Microbiol. 2010 Sep 1;12(9):1308-21
references: 20345487
references: J Infect Dis. 1985 Sep;152(3):550-9
references: 2863318
references: PLoS Pathog. 2008 Oct;4(10):e1000191
references: 18974829
references: J Cell Physiol. 1985 Jun;123(3):377-85
references: 2985631
references: Cell. 2006 Jan 13;124(1):133-45
references: 16413487
references: J Clin Invest. 2001 Mar;107(5):621-9
references: 11238563